Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the current
pandemic of coronavirus disease 2019 (COVID-19) that have killed over one million people …

As the world progressively recovers from the acute stages of the coronavirus disease 2019
(COVID-19) pandemic, we may be facing new challenges regarding the long-term …

It has been suggested that pulmonary arterial hypertension (PAH) could be a potential
sequela of coronavirus disease 2019 (COVID-19) in particular in those with hypertension; …

Coronavirus disease (COVID-19), first described in Wuhan, China, in December 2019, is
caused by a new coronavirus called severe acute respiratory syndrome coronavirus 2 …

The lungs are the primary target of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection, with severe hypoxia being the cause of death in the most critical cases …

The number of coronavirus disease 2019 (COVID‐19) cases has been increasing
significantly, and the disease has evolved into a global pandemic, posing an unprecedented …

Since the beginning of the SARS-CoV-2 outbreak, few cases of COVID-19 pneumonia in
patients with pulmonary arterial hypertension have been reported. We present four patients …

In the last few months, the number of cases of a new coronavirus-related disease (COVID-
19) rose exponentially, reaching the status of a pandemic. Interestingly, early imaging …

Coronavirus disease 2019 (COVID-19) is a primary respiratory infectious disease, which can
result in pulmonary and cardiovascular complications. From its first appearance in the city of …

(1) Background: While the COVID-19 pandemic has been persisting for almost 2 years, more
and more people are diagnosed with residual complications such as pulmonary …